RELATED ATTORNEYS
Gary Speier while at a previous law firm represented Pack in an Inter Partes Review concerning Pack’s Paragraph IV ANDA challenge of 1 patent covering the formulation of glipizide (Glucotrol® XL) [IPR2014-00868]. He achieved a successful settlement prior to the institution of the IPR.